Crossmark

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

Crossref DOI link: https://doi.org/10.1186/s13643-018-0805-7

Published Online: 2018-09-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Almasri, Jehad https://orcid.org/0000-0001-6098-8450
Alkhateeb, Hassan B.

Firwana, Belal

Sonbol, Mohamad Bassam

Damlaj, Moussab

Wang, Zhen

Murad, M. Hassan

Al-Kali, Aref
License Information

Text and Data Mining valid from 2018-09-19
More Information

Article History

Received: 2 October 2017

Accepted: 30 August 2018

First Online: 19 September 2018

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.